Brainsway (BRSYF) Shares Outstanding (Weighted Average) (2018 - 2026)
Brainsway (BRSYF) reported Shares Outstanding (Weighted Average) of $60.0 for Q1 2026, up 100.0% on a YoY basis from $30.0 in Q1 2025, and down 100.0% quarter-over-quarter from $162.2 million in Q4 2025.
Brainsway (BRSYF) Shares Outstanding (Weighted Average) (2018 - 2026) Analysis & Trends
Brainsway has reported Shares Outstanding (Weighted Average) for 9 years, with the latest figure at $60.0 in Q1 2026.
- For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 100.0% year-over-year to $60.0; the trailing twelve-month figure through Mar 2026 stood at $60.0 (up 100.0% YoY), and the FY2025 full-year result was $200.0, down 100.0% from the prior year.
- Shares Outstanding (Weighted Average) for Q1 2026 stood at $60.0, down from $162.2 million in the prior quarter.
- The five-year high for Shares Outstanding (Weighted Average) was $162.2 million in Q4 2025, with the low at $30.0 in Q1 2025.
- Historically, Shares Outstanding (Weighted Average) has averaged $90.6 million across 5 years, with a median of $137.9 million in 2022.
- The largest YoY upside for Shares Outstanding (Weighted Average) was 399682400.0% in 2025 against a maximum downside of 100.0% in 2025.
- Brainsway's Shares Outstanding (Weighted Average) stood at $33.0 million in 2022, then rose by 0.53% to $33.2 million in 2023, then grew by 13.48% to $37.6 million in 2024, then surged by 331.14% to $162.2 million in 2025, then slumped by 100.0% to $60.0 in 2026.
- The last three Shares Outstanding (Weighted Average) figures came in at $60.0 (Q1 2026), $162.2 million (Q4 2025), and $159.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.28 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 385.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 98.20 Mn |
| 10 | Brainsway | - | - | 11.68 Mn | 60.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 60.00 |
| Dec 31, 2025 | 162.22 Mn |
| Sep 30, 2025 | 159.87 Mn |
| Jun 30, 2025 | 80.00 |
| Mar 31, 2025 | 30.00 |
| Dec 31, 2024 | 37.63 Mn |
| Sep 30, 2024 | 40.00 |
| Jun 30, 2024 | 140.66 Mn |
| Mar 31, 2024 | 140.45 Mn |
| Dec 31, 2023 | 33.16 Mn |
| Sep 30, 2023 | 140.95 Mn |
| Jun 30, 2023 | 140.55 Mn |
| Mar 31, 2023 | 138.15 Mn |
| Dec 31, 2022 | 32.98 Mn |
| Sep 30, 2022 | 137.94 Mn |
| Jun 30, 2022 | 137.90 Mn |
| Mar 31, 2022 | 137.81 Mn |
| Dec 31, 2021 | 31.15 Mn |
| Sep 30, 2021 | 137.56 Mn |
| Jun 30, 2021 | 137.34 Mn |